GDF15 and COVID-19: In the present study, we aimed to quantify the circulating levels of novel serum biomarkers including GDF-15, PIVKA-II, sdLDL, suPAR, and of CRP in hospitalized COVID-19 patients compared with healthy subjects and to evaluate their association(s) with outcomes in COVID-19.